Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for Quadriceps Function in TKA
NCT02319343Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Jan 2015
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Methylprednisolone with Placebo (2 arms). Primary endpoint: Change in isometric knee extension strength. Started Jan 2015; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02319343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02319343.